{"componentChunkName":"component---utcom-root-cache-master-unitedtraders-plugin-utcom-feed-virtual-f-1-ca-34-a-2-da-node-modules-unitedtraders-plugin-utcom-feed-dist-screens-post-screen-index-js","path":"/feed/conversion-of-ginkgo-bioworks-shares","matchPath":"/feed/conversion-of-ginkgo-bioworks-shares/*","result":{"pageContext":{"matchPath":"/feed/conversion-of-ginkgo-bioworks-shares/*","post":{"backgroundColor":"#C8F4EA","date":"2021-12-02T14:30:00.000Z","foregroundColor":"#000000","linkOpenNewTab":false,"id":"Enpost_97","isPublic":true,"leadParagraph":"In September, the company went public through SPAC. Ginkgo Bioworks shares were converted into the shares of a new public company with a coefficient of 49.08x. The return on investment at the pre-IPO stage to the company's entry point was +254%.","link":"https://unitedtraders.com/investments/open-investment","linkText":"View portfolio","metaDescription":"Ginkgo Bioworks","metaKeywords":"United Traders Feed","metaTitle":"Ginkgo Bioworks","path":"conversion-of-ginkgo-bioworks-shares","text":"Biotech Ginkgo Bioworks produces bacteria for industrial purposes. In September, Ginkgo Bioworks went public through a SPAC company with a DNA ticker.\n\nGinkgo shares were converted into shares of a new public company with a coefficient of 49.08x. In other words, the company implemented a stock split: the number of issued shares increased by 49.08 times, and their price decreased by 49.08 times.\n\nA similar conversion has been implemented on the United Traders platform. In October 2020, when we first offered to invest in Ginkgo Bioworks, the price per share was $138.6. As a result of conversion, the price per share decreased to $2.82. When the company went public through SPAC, its shares were valued at $10. Thus, the return on investment at the pre-IPO stage to the company's exit point ($10) is 254%.\n\nWe'd like to remind you that for those, who invest at the pre-IPO stage, there is a lock-up period of 180 days after the placement date, expiring on March 16, 2022. After that, we will start transferring shares to our brokerage account.\n","title":"Conversion of Ginkgo Bioworks shares","type":"POST","poster":{"childImageSharp":{"fluid":{"aspectRatio":3.508771929824561,"src":"https://4e49aa661b9f.unitedtraders.io/bundles/2.8774.0/en/static/f99e6f6a354439d8f4b159453a4ba9c7/ee604/13c2ed5a08434d0e964180b5eb6c7fdb.png","srcSet":"https://4e49aa661b9f.unitedtraders.io/bundles/2.8774.0/en/static/f99e6f6a354439d8f4b159453a4ba9c7/69585/13c2ed5a08434d0e964180b5eb6c7fdb.png 200w,\nhttps://4e49aa661b9f.unitedtraders.io/bundles/2.8774.0/en/static/f99e6f6a354439d8f4b159453a4ba9c7/497c6/13c2ed5a08434d0e964180b5eb6c7fdb.png 400w,\nhttps://4e49aa661b9f.unitedtraders.io/bundles/2.8774.0/en/static/f99e6f6a354439d8f4b159453a4ba9c7/ee604/13c2ed5a08434d0e964180b5eb6c7fdb.png 800w,\nhttps://4e49aa661b9f.unitedtraders.io/bundles/2.8774.0/en/static/f99e6f6a354439d8f4b159453a4ba9c7/f3583/13c2ed5a08434d0e964180b5eb6c7fdb.png 1200w,\nhttps://4e49aa661b9f.unitedtraders.io/bundles/2.8774.0/en/static/f99e6f6a354439d8f4b159453a4ba9c7/814b6/13c2ed5a08434d0e964180b5eb6c7fdb.png 1420w","sizes":"(max-width: 800px) 100vw, 800px"}}}},"lang":"en","localeResources":{"nodes":[{"id":"265328c5-1b6b-54fb-be5d-065ade3996c3","name":"footer","lng":"en","translations":[{"key":"Mobile Apps","value":"Mobile Apps"},{"key":"Available on the","value":"Available on the"},{"key":"Get it on","value":"Get it on"},{"key":"Social","value":"Social media"},{"key":"Sections","value":"Sections"},{"key":"Partnership","value":"Partnership"},{"key":"Traiding","value":"Trading"},{"key":"Contacts","value":"Contacts"},{"key":"Help","value":"Help"},{"key":"Telegram","value":"Telegram"},{"key":"Whatsapp","value":"WhatsApp"},{"key":"Email","value":"Email"},{"key":"Documents","value":"Legal"},{"key":"License agreement","value":"License Agreement"},{"key":"Risk Statement","value":"Risk Statement"},{"key":"Privacy policy","value":"Privacy Policy"}]},{"id":"29a9d18c-3f68-5922-bbe9-3f27c4dcd333","name":"links","lng":"en","translations":[{"key":"app-store-link","value":"https://apps.apple.com/ru/app/united-traders/id1491324321"},{"key":"google-play-link","value":"https://play.google.com/store/apps/details?id=com.unitedtraders.mobile.investment"},{"key":"yt-link","value":"https://www.youtube.com/user/theunitedtraders"},{"key":"tg-link","value":"https://t.me/uttokenchannel"},{"key":"tw-link","value":"https://twitter.com/UnitedTraders_1"},{"key":"partnership-link","value":"https://partners.utex.io"},{"key":"traiding-link","value":"/trading/analytics"},{"key":"contacts-link","value":"/contacts"},{"key":"tg-bot-link","value":"https://t.me/ut_personal_manager_bot"},{"key":"whatsapp-link","value":"https://wa.me/79959221420"},{"key":"email-link","value":"mailto:welcome@unitedtraders.com"},{"key":"agreement-link","value":"/offer"},{"key":"risk-link","value":"https://investment-s3.unitedtraders.io/files/Risk_Statement_UT_Overseas_170918.pdf"},{"key":"privacy-link","value":"https://investment-s3.unitedtraders.io/files/privacy-policy_en.pdf"}]},{"id":"a86af053-df7e-524e-abcd-94930796adc6","name":"tabbar","lng":"en","translations":[{"key":"Feed","value":"Feed"},{"key":"Ideas","value":"Ideas"},{"key":"Case","value":"Portfolio"},{"key":"Help","value":"Help"}]},{"id":"92d8a8e6-31e0-565e-89db-cd6ab0af8750","name":"feedMeta","lng":"en","translations":[{"key":"Investment news","value":"Investment news: IPO, pre-IPO, OTC"},{"key":"Investment news description","value":"Investment news: IPO, pre-IPO, OTC"},{"key":"United Traders Feed","value":"United Traders Feed"},{"key":"United Traders Feed title","value":"United Traders Feed"},{"key":"keywords","value":"investments, ipo, pre-ipo, otc"}]},{"id":"e7b227e5-160c-5cd0-a214-6e4ae45a1e1c","name":"feedMain","lng":"en","translations":[{"key":"feed","value":"Feed"},{"key":"read more","value":"Read more"}]}]},"basePath":"feed","isFeed":true}},"staticQueryHashes":[]}